Development and production of parenteral dosage forms for clinical studies, 09/20/2013-09/19/2018

Ended Awarded Last action

Contract number
HHSN261201300033I
Awardee
Awarding agency
Task orders
1 $1,000 obligated

Award facts

Opportunity
Combined order value
$1,000 Current and potential, with all options
Last date to order 100% complete
IDV ceiling <1% used
$8,463,789.00
Award type
Multiple award
Who can order
Only the awarding agency
Set-aside
Partial Small Business
Competition
Full and Open Competition after exclusion of sources · 3 offers Negotiated Proposal / Quote
Pricing
Order Dependent (IDV only)

Award details come from SAM.gov/FPDS.

Task orders

Transactions

Action Obligated Date
Other Administrative Action 2 $0
Other Administrative Action 1 $0
Original award $0

Quick answers

Who was awarded contract HHSN261201300033I?

HHSN261201300033I was awarded to Eurofins Advantar Laboratories, LLC by National Cancer Institute (National Institutes of Health) on September 20, 2013.

How much is contract HHSN261201300033I worth?

Orders under HHSN261201300033I have obligated $1,000. HHSN261201300033I's own ceiling is $8,463,789.

How many orders have been placed under contract HHSN261201300033I?

1 order has been placed under HHSN261201300033I, the latest on September 20, 2013.

Who can order from contract HHSN261201300033I?

HHSN261201300033I is a multiple award indefinite delivery contract. Only the awarding agency can place orders on it.

Is contract HHSN261201300033I part of a contract vehicle?

Yes. HHSN261201300033I is part of Parenteral Dosage Forms for Clinical Studies.

Was contract HHSN261201300033I competed?

The extent of competition for HHSN261201300033I was full and open competition after exclusion of sources. The government received 3 offers. It was set aside: Partial Small Business.

On GovTribe

See this IDV's full record

  • Every order and transaction
  • The awardee's other awards and teaming partners
  • Similar IDVs and recompete opportunities
  • Ask GovTribe AI about this IDV